nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP3A4—Temozolomide—malignant glioma	0.133	1	CbGbCtD
Prochlorperazine—HTR2C—choroid plexus—malignant glioma	0.0911	0.311	CbGeAlD
Prochlorperazine—Abnormal pigmentation—Temozolomide—malignant glioma	0.0704	0.144	CcSEcCtD
Prochlorperazine—DRD3—telencephalic ventricle—malignant glioma	0.048	0.164	CbGeAlD
Prochlorperazine—Edema cerebral—Carmustine—malignant glioma	0.0444	0.0906	CcSEcCtD
Prochlorperazine—Edema cerebral—Temozolomide—malignant glioma	0.0429	0.0876	CcSEcCtD
Prochlorperazine—HTR2C—telencephalic ventricle—malignant glioma	0.0267	0.0912	CbGeAlD
Prochlorperazine—Brain oedema—Carmustine—malignant glioma	0.024	0.049	CcSEcCtD
Prochlorperazine—Brain oedema—Temozolomide—malignant glioma	0.0232	0.0474	CcSEcCtD
Prochlorperazine—DRD2—telencephalic ventricle—malignant glioma	0.0203	0.0694	CbGeAlD
Prochlorperazine—Pigmentation disorder—Temozolomide—malignant glioma	0.0199	0.0406	CcSEcCtD
Prochlorperazine—Altered state of consciousness—Temozolomide—malignant glioma	0.0144	0.0293	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Temozolomide—malignant glioma	0.0109	0.0223	CcSEcCtD
Prochlorperazine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00881	0.018	CcSEcCtD
Prochlorperazine—Cholestasis—Temozolomide—malignant glioma	0.00873	0.0178	CcSEcCtD
Prochlorperazine—Liver injury—Temozolomide—malignant glioma	0.00788	0.0161	CcSEcCtD
Prochlorperazine—Amenorrhoea—Temozolomide—malignant glioma	0.00755	0.0154	CcSEcCtD
Prochlorperazine—HTR2C—brainstem—malignant glioma	0.00722	0.0247	CbGeAlD
Prochlorperazine—Gait disturbance—Carmustine—malignant glioma	0.00703	0.0144	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Carmustine—malignant glioma	0.00686	0.014	CcSEcCtD
Prochlorperazine—Gait disturbance—Temozolomide—malignant glioma	0.0068	0.0139	CcSEcCtD
Prochlorperazine—CHRM2—telencephalon—malignant glioma	0.00665	0.0227	CbGeAlD
Prochlorperazine—Pulmonary embolism—Temozolomide—malignant glioma	0.00663	0.0135	CcSEcCtD
Prochlorperazine—DRD3—central nervous system—malignant glioma	0.00655	0.0224	CbGeAlD
Prochlorperazine—HTR2C—telencephalon—malignant glioma	0.00641	0.0219	CbGeAlD
Prochlorperazine—Coma—Carmustine—malignant glioma	0.00627	0.0128	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Temozolomide—malignant glioma	0.00623	0.0127	CcSEcCtD
Prochlorperazine—Gynaecomastia—Carmustine—malignant glioma	0.00614	0.0125	CcSEcCtD
Prochlorperazine—DRD2—brainstem—malignant glioma	0.00549	0.0188	CbGeAlD
Prochlorperazine—DRD2—retina—malignant glioma	0.0053	0.0181	CbGeAlD
Prochlorperazine—Nasal congestion—Temozolomide—malignant glioma	0.00529	0.0108	CcSEcCtD
Prochlorperazine—DRD3—brain—malignant glioma	0.0052	0.0178	CbGeAlD
Prochlorperazine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0051	0.0104	CcSEcCtD
Prochlorperazine—HTR2C—medulla oblongata—malignant glioma	0.00503	0.0172	CbGeAlD
Prochlorperazine—DRD2—telencephalon—malignant glioma	0.00487	0.0167	CbGeAlD
Prochlorperazine—Trifluoperazine—CALY—malignant glioma	0.00484	0.167	CrCbGaD
Prochlorperazine—HTR2C—midbrain—malignant glioma	0.0046	0.0157	CbGeAlD
Prochlorperazine—HTR2C—spinal cord—malignant glioma	0.00449	0.0153	CbGeAlD
Prochlorperazine—Dysphagia—Carmustine—malignant glioma	0.00431	0.00879	CcSEcCtD
Prochlorperazine—Dysphagia—Temozolomide—malignant glioma	0.00416	0.0085	CcSEcCtD
Prochlorperazine—Pancytopenia—Carmustine—malignant glioma	0.00409	0.00835	CcSEcCtD
Prochlorperazine—Clozapine—CALY—malignant glioma	0.00403	0.14	CrCbGaD
Prochlorperazine—Pancytopenia—Temozolomide—malignant glioma	0.00395	0.00807	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Carmustine—malignant glioma	0.00388	0.00793	CcSEcCtD
Prochlorperazine—HRH1—telencephalon—malignant glioma	0.00385	0.0132	CbGeAlD
Prochlorperazine—Erectile dysfunction—Temozolomide—malignant glioma	0.00383	0.00783	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Temozolomide—malignant glioma	0.0038	0.00776	CcSEcCtD
Prochlorperazine—Weight increased—Temozolomide—malignant glioma	0.00379	0.00773	CcSEcCtD
Prochlorperazine—CHRM2—central nervous system—malignant glioma	0.00378	0.0129	CbGeAlD
Prochlorperazine—Hyperglycaemia—Temozolomide—malignant glioma	0.00375	0.00767	CcSEcCtD
Prochlorperazine—HTR2C—central nervous system—malignant glioma	0.00364	0.0124	CbGeAlD
Prochlorperazine—DRD2—midbrain—malignant glioma	0.0035	0.012	CbGeAlD
Prochlorperazine—Oedema peripheral—Carmustine—malignant glioma	0.0034	0.00693	CcSEcCtD
Prochlorperazine—CYP2D6—brainstem—malignant glioma	0.0033	0.0113	CbGeAlD
Prochlorperazine—Oedema peripheral—Temozolomide—malignant glioma	0.00328	0.0067	CcSEcCtD
Prochlorperazine—Erythema multiforme—Temozolomide—malignant glioma	0.00315	0.00643	CcSEcCtD
Prochlorperazine—Arrhythmia—Carmustine—malignant glioma	0.00308	0.00629	CcSEcCtD
Prochlorperazine—Erythema—Carmustine—malignant glioma	0.003	0.00613	CcSEcCtD
Prochlorperazine—CHRM2—brain—malignant glioma	0.003	0.0103	CbGeAlD
Prochlorperazine—CYP2D6—telencephalon—malignant glioma	0.00293	0.01	CbGeAlD
Prochlorperazine—Erythema—Temozolomide—malignant glioma	0.0029	0.00592	CcSEcCtD
Prochlorperazine—HTR2C—brain—malignant glioma	0.00289	0.00988	CbGeAlD
Prochlorperazine—Vision blurred—Carmustine—malignant glioma	0.00283	0.00577	CcSEcCtD
Prochlorperazine—Tremor—Carmustine—malignant glioma	0.00281	0.00574	CcSEcCtD
Prochlorperazine—DRD2—central nervous system—malignant glioma	0.00277	0.00947	CbGeAlD
Prochlorperazine—Agitation—Carmustine—malignant glioma	0.00276	0.00563	CcSEcCtD
Prochlorperazine—Vision blurred—Temozolomide—malignant glioma	0.00273	0.00558	CcSEcCtD
Prochlorperazine—Tremor—Temozolomide—malignant glioma	0.00272	0.00555	CcSEcCtD
Prochlorperazine—DRD2—cerebellum—malignant glioma	0.00271	0.00925	CbGeAlD
Prochlorperazine—Leukopenia—Carmustine—malignant glioma	0.00269	0.00548	CcSEcCtD
Prochlorperazine—Agitation—Temozolomide—malignant glioma	0.00266	0.00544	CcSEcCtD
Prochlorperazine—Angioedema—Temozolomide—malignant glioma	0.00265	0.00541	CcSEcCtD
Prochlorperazine—Convulsion—Carmustine—malignant glioma	0.0026	0.00531	CcSEcCtD
Prochlorperazine—Leukopenia—Temozolomide—malignant glioma	0.0026	0.0053	CcSEcCtD
Prochlorperazine—Cough—Temozolomide—malignant glioma	0.00253	0.00517	CcSEcCtD
Prochlorperazine—Convulsion—Temozolomide—malignant glioma	0.00251	0.00513	CcSEcCtD
Prochlorperazine—Oedema—Carmustine—malignant glioma	0.00245	0.005	CcSEcCtD
Prochlorperazine—Infection—Carmustine—malignant glioma	0.00243	0.00497	CcSEcCtD
Prochlorperazine—Dry mouth—Temozolomide—malignant glioma	0.00241	0.00493	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Carmustine—malignant glioma	0.0024	0.0049	CcSEcCtD
Prochlorperazine—Oedema—Temozolomide—malignant glioma	0.00237	0.00483	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Temozolomide—malignant glioma	0.00237	0.00483	CcSEcCtD
Prochlorperazine—Infection—Temozolomide—malignant glioma	0.00235	0.0048	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Temozolomide—malignant glioma	0.00232	0.00473	CcSEcCtD
Prochlorperazine—Skin disorder—Temozolomide—malignant glioma	0.0023	0.00469	CcSEcCtD
Prochlorperazine—Hypotension—Carmustine—malignant glioma	0.00229	0.00467	CcSEcCtD
Prochlorperazine—Insomnia—Carmustine—malignant glioma	0.00221	0.00452	CcSEcCtD
Prochlorperazine—DRD2—brain—malignant glioma	0.0022	0.00752	CbGeAlD
Prochlorperazine—HRH1—central nervous system—malignant glioma	0.00219	0.00748	CbGeAlD
Prochlorperazine—Dyspnoea—Carmustine—malignant glioma	0.00218	0.00446	CcSEcCtD
Prochlorperazine—Somnolence—Carmustine—malignant glioma	0.00218	0.00445	CcSEcCtD
Prochlorperazine—Insomnia—Temozolomide—malignant glioma	0.00214	0.00437	CcSEcCtD
Prochlorperazine—Dyspnoea—Temozolomide—malignant glioma	0.00211	0.00431	CcSEcCtD
Prochlorperazine—Somnolence—Temozolomide—malignant glioma	0.0021	0.0043	CcSEcCtD
Prochlorperazine—Constipation—Carmustine—malignant glioma	0.00209	0.00428	CcSEcCtD
Prochlorperazine—Constipation—Temozolomide—malignant glioma	0.00202	0.00413	CcSEcCtD
Prochlorperazine—Body temperature increased—Carmustine—malignant glioma	0.00194	0.00395	CcSEcCtD
Prochlorperazine—Urticaria—Temozolomide—malignant glioma	0.00188	0.00384	CcSEcCtD
Prochlorperazine—Body temperature increased—Temozolomide—malignant glioma	0.00187	0.00382	CcSEcCtD
Prochlorperazine—Hypersensitivity—Carmustine—malignant glioma	0.0018	0.00368	CcSEcCtD
Prochlorperazine—Hypersensitivity—Temozolomide—malignant glioma	0.00174	0.00356	CcSEcCtD
Prochlorperazine—HRH1—brain—malignant glioma	0.00174	0.00593	CbGeAlD
Prochlorperazine—Domperidone—CYP2B6—malignant glioma	0.0017	0.0587	CrCbGaD
Prochlorperazine—CYP3A4—central nervous system—malignant glioma	0.00169	0.00578	CbGeAlD
Prochlorperazine—Pruritus—Temozolomide—malignant glioma	0.00167	0.00342	CcSEcCtD
Prochlorperazine—CYP2D6—central nervous system—malignant glioma	0.00166	0.00569	CbGeAlD
Prochlorperazine—Clobazam—CYP2C18—malignant glioma	0.00165	0.057	CrCbGaD
Prochlorperazine—CYP2D6—cerebellum—malignant glioma	0.00163	0.00556	CbGeAlD
Prochlorperazine—Dizziness—Carmustine—malignant glioma	0.00162	0.00331	CcSEcCtD
Prochlorperazine—Dizziness—Temozolomide—malignant glioma	0.00156	0.0032	CcSEcCtD
Prochlorperazine—Rash—Carmustine—malignant glioma	0.00154	0.00315	CcSEcCtD
Prochlorperazine—Dermatitis—Carmustine—malignant glioma	0.00154	0.00315	CcSEcCtD
Prochlorperazine—Headache—Carmustine—malignant glioma	0.00153	0.00313	CcSEcCtD
Prochlorperazine—Rash—Temozolomide—malignant glioma	0.00149	0.00305	CcSEcCtD
Prochlorperazine—Dermatitis—Temozolomide—malignant glioma	0.00149	0.00304	CcSEcCtD
Prochlorperazine—Headache—Temozolomide—malignant glioma	0.00148	0.00303	CcSEcCtD
Prochlorperazine—Ethopropazine—BCHE—malignant glioma	0.00137	0.0474	CrCbGaD
Prochlorperazine—CYP2D6—brain—malignant glioma	0.00132	0.00452	CbGeAlD
Prochlorperazine—Clobazam—CYP2B6—malignant glioma	0.00122	0.0423	CrCbGaD
Prochlorperazine—Nefazodone—SLC6A3—malignant glioma	0.0012	0.0415	CrCbGaD
Prochlorperazine—Clomipramine—GSTP1—malignant glioma	0.00115	0.0397	CrCbGaD
Prochlorperazine—Perphenazine—CYP2C18—malignant glioma	0.00112	0.0389	CrCbGaD
Prochlorperazine—Triflupromazine—BCHE—malignant glioma	0.00112	0.0388	CrCbGaD
Prochlorperazine—Mianserin—CYP2B6—malignant glioma	0.00106	0.0365	CrCbGaD
Prochlorperazine—Desipramine—CYP2C18—malignant glioma	0.00105	0.0362	CrCbGaD
Prochlorperazine—Mianserin—SLC6A3—malignant glioma	0.000899	0.0311	CrCbGaD
Prochlorperazine—Imipramine—CYP2C18—malignant glioma	0.000887	0.0307	CrCbGaD
Prochlorperazine—Promethazine—CYP2B6—malignant glioma	0.000855	0.0296	CrCbGaD
Prochlorperazine—Perphenazine—CYP2B6—malignant glioma	0.000834	0.0289	CrCbGaD
Prochlorperazine—Desipramine—CYP2B6—malignant glioma	0.000777	0.0269	CrCbGaD
Prochlorperazine—Loxapine—SLC6A3—malignant glioma	0.000714	0.0247	CrCbGaD
Prochlorperazine—Desipramine—SLC6A3—malignant glioma	0.000662	0.0229	CrCbGaD
Prochlorperazine—Imipramine—CYP2B6—malignant glioma	0.000659	0.0228	CrCbGaD
Prochlorperazine—Imipramine—SLC6A3—malignant glioma	0.000561	0.0194	CrCbGaD
Prochlorperazine—Chlorpromazine—BCHE—malignant glioma	0.00054	0.0187	CrCbGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CG—malignant glioma	1.91e-05	0.000342	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—APC—malignant glioma	1.91e-05	0.000342	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—FGFR1—malignant glioma	1.91e-05	0.000342	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—RAF1—malignant glioma	1.9e-05	0.000342	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	1.9e-05	0.000341	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	1.89e-05	0.00034	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGF—malignant glioma	1.89e-05	0.000338	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PDGFRA—malignant glioma	1.88e-05	0.000338	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—IL2—malignant glioma	1.88e-05	0.000337	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HIF1A—malignant glioma	1.88e-05	0.000337	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—BCHE—malignant glioma	1.88e-05	0.000336	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTPN11—malignant glioma	1.87e-05	0.000336	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	1.87e-05	0.000336	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	1.86e-05	0.000333	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.85e-05	0.000332	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	1.85e-05	0.000332	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	1.85e-05	0.000332	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—IDH1—malignant glioma	1.84e-05	0.000329	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	1.83e-05	0.000328	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SPP1—malignant glioma	1.83e-05	0.000328	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCL8—malignant glioma	1.82e-05	0.000326	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	1.82e-05	0.000326	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CAV1—malignant glioma	1.82e-05	0.000326	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KDR—malignant glioma	1.8e-05	0.000322	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SPP1—malignant glioma	1.79e-05	0.000322	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—BRAF—malignant glioma	1.79e-05	0.000322	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	1.79e-05	0.00032	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SPHK1—malignant glioma	1.78e-05	0.000319	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SPP1—malignant glioma	1.77e-05	0.000317	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	1.76e-05	0.000315	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT2—malignant glioma	1.74e-05	0.000313	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.74e-05	0.000312	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL2—malignant glioma	1.74e-05	0.000312	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—EGFR—malignant glioma	1.74e-05	0.000312	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TERT—malignant glioma	1.73e-05	0.000311	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—FN1—malignant glioma	1.73e-05	0.00031	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—F2—malignant glioma	1.73e-05	0.00031	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—BAD—malignant glioma	1.71e-05	0.000306	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL2—malignant glioma	1.71e-05	0.000306	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TERT—malignant glioma	1.7e-05	0.000305	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NOTCH1—malignant glioma	1.69e-05	0.000303	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PDGFB—malignant glioma	1.69e-05	0.000303	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FGFR1—malignant glioma	1.68e-05	0.000302	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL2—malignant glioma	1.68e-05	0.000301	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CD—malignant glioma	1.68e-05	0.000301	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TERT—malignant glioma	1.67e-05	0.0003	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—PIK3CA—malignant glioma	1.66e-05	0.000298	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PDGFB—malignant glioma	1.66e-05	0.000298	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CD80—malignant glioma	1.66e-05	0.000297	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HIF1A—malignant glioma	1.66e-05	0.000297	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—APC—malignant glioma	1.65e-05	0.000297	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CG—malignant glioma	1.65e-05	0.000297	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FGFR1—malignant glioma	1.65e-05	0.000296	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—KRAS—malignant glioma	1.64e-05	0.000294	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGF—malignant glioma	1.63e-05	0.000293	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	1.63e-05	0.000293	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HIF1A—malignant glioma	1.63e-05	0.000292	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	1.62e-05	0.000291	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTPN11—malignant glioma	1.62e-05	0.000291	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—FGF2—malignant glioma	1.61e-05	0.000288	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CAV1—malignant glioma	1.6e-05	0.000287	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	1.6e-05	0.000287	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KDR—malignant glioma	1.58e-05	0.000284	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CAV1—malignant glioma	1.57e-05	0.000282	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KDR—malignant glioma	1.56e-05	0.000279	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—BRAF—malignant glioma	1.55e-05	0.000279	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CAV1—malignant glioma	1.55e-05	0.000278	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KDR—malignant glioma	1.53e-05	0.000275	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—F2—malignant glioma	1.52e-05	0.000274	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FN1—malignant glioma	1.52e-05	0.000274	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT2—malignant glioma	1.51e-05	0.000271	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—PIK3CA—malignant glioma	1.51e-05	0.000271	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BAD—malignant glioma	1.51e-05	0.00027	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EGFR—malignant glioma	1.51e-05	0.00027	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MDM2—malignant glioma	1.5e-05	0.000269	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—F2—malignant glioma	1.5e-05	0.000269	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FN1—malignant glioma	1.5e-05	0.000269	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RAF1—malignant glioma	1.5e-05	0.000269	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	1.49e-05	0.000268	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTP1—malignant glioma	1.49e-05	0.000268	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ERBB2—malignant glioma	1.48e-05	0.000266	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BAD—malignant glioma	1.48e-05	0.000265	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FN1—malignant glioma	1.47e-05	0.000264	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—F2—malignant glioma	1.47e-05	0.000264	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	1.47e-05	0.000263	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CD80—malignant glioma	1.46e-05	0.000262	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CB—malignant glioma	1.46e-05	0.000262	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APC—malignant glioma	1.46e-05	0.000262	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	1.46e-05	0.000262	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BAD—malignant glioma	1.46e-05	0.000261	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	1.45e-05	0.000261	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CAT—malignant glioma	1.45e-05	0.00026	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGF—malignant glioma	1.44e-05	0.000259	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	1.44e-05	0.000259	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	1.44e-05	0.000258	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CD80—malignant glioma	1.44e-05	0.000258	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTPN11—malignant glioma	1.43e-05	0.000257	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APC—malignant glioma	1.43e-05	0.000257	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	1.43e-05	0.000257	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—KRAS—malignant glioma	1.42e-05	0.000255	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGF—malignant glioma	1.42e-05	0.000254	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CD80—malignant glioma	1.41e-05	0.000253	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APC—malignant glioma	1.41e-05	0.000253	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	1.41e-05	0.000253	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTPN11—malignant glioma	1.41e-05	0.000253	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTT1—malignant glioma	1.41e-05	0.000252	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—malignant glioma	1.4e-05	0.000252	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGF—malignant glioma	1.39e-05	0.00025	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—FGF2—malignant glioma	1.39e-05	0.00025	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	1.39e-05	0.000248	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BRAF—malignant glioma	1.37e-05	0.000246	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NCOR1—malignant glioma	1.37e-05	0.000246	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—malignant glioma	1.36e-05	0.000243	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BRAF—malignant glioma	1.35e-05	0.000242	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—malignant glioma	1.34e-05	0.000241	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL2—malignant glioma	1.34e-05	0.000241	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT2—malignant glioma	1.34e-05	0.00024	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—malignant glioma	1.33e-05	0.000239	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BRAF—malignant glioma	1.33e-05	0.000238	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS1—malignant glioma	1.32e-05	0.000237	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT2—malignant glioma	1.31e-05	0.000235	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	1.31e-05	0.000235	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—malignant glioma	1.31e-05	0.000234	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MDM2—malignant glioma	1.3e-05	0.000234	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAF1—malignant glioma	1.3e-05	0.000233	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT2—malignant glioma	1.29e-05	0.000231	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	1.28e-05	0.00023	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	1.28e-05	0.00023	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	1.28e-05	0.00023	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	1.27e-05	0.000228	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—malignant glioma	1.27e-05	0.000228	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	1.27e-05	0.000227	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTEN—malignant glioma	1.26e-05	0.000227	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	1.26e-05	0.000226	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—KRAS—malignant glioma	1.26e-05	0.000225	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	1.25e-05	0.000224	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	1.24e-05	0.000222	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—KRAS—malignant glioma	1.23e-05	0.000221	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—malignant glioma	1.23e-05	0.000221	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—FGF2—malignant glioma	1.23e-05	0.00022	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	1.23e-05	0.00022	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—BCHE—malignant glioma	1.23e-05	0.00022	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	1.22e-05	0.000218	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	1.21e-05	0.000218	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.21e-05	0.000217	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—FGF2—malignant glioma	1.21e-05	0.000216	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—FGF2—malignant glioma	1.19e-05	0.000213	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	1.18e-05	0.000211	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—malignant glioma	1.17e-05	0.000209	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL2—malignant glioma	1.16e-05	0.000209	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	1.15e-05	0.000207	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MDM2—malignant glioma	1.15e-05	0.000206	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAF1—malignant glioma	1.15e-05	0.000205	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—malignant glioma	1.14e-05	0.000205	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ERBB2—malignant glioma	1.13e-05	0.000203	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	1.13e-05	0.000203	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—malignant glioma	1.13e-05	0.000203	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MDM2—malignant glioma	1.13e-05	0.000202	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAF1—malignant glioma	1.12e-05	0.000202	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	1.12e-05	0.000201	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CAV1—malignant glioma	1.12e-05	0.000201	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	1.11e-05	0.0002	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ERBB2—malignant glioma	1.11e-05	0.0002	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MDM2—malignant glioma	1.11e-05	0.000199	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAF1—malignant glioma	1.11e-05	0.000199	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—malignant glioma	1.1e-05	0.000198	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	1.1e-05	0.000197	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTEN—malignant glioma	1.09e-05	0.000196	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	1.09e-05	0.000196	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	1.08e-05	0.000194	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	1.07e-05	0.000193	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	1.07e-05	0.000192	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—malignant glioma	1.06e-05	0.000189	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—malignant glioma	1.05e-05	0.000188	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	1.04e-05	0.000186	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	1.04e-05	0.000186	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—malignant glioma	1.03e-05	0.000185	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL2—malignant glioma	1.03e-05	0.000184	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—malignant glioma	1.03e-05	0.000184	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	1.02e-05	0.000183	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.02e-05	0.000183	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—malignant glioma	1.01e-05	0.000181	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL2—malignant glioma	1.01e-05	0.000181	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	1e-05	0.00018	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—malignant glioma	9.94e-06	0.000178	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL2—malignant glioma	9.92e-06	0.000178	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	9.89e-06	0.000177	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PPARG—malignant glioma	9.83e-06	0.000176	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—malignant glioma	9.79e-06	0.000176	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTP1—malignant glioma	9.75e-06	0.000175	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—malignant glioma	9.72e-06	0.000174	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KRAS—malignant glioma	9.7e-06	0.000174	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTEN—malignant glioma	9.66e-06	0.000173	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—malignant glioma	9.54e-06	0.000171	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CAT—malignant glioma	9.49e-06	0.00017	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTEN—malignant glioma	9.49e-06	0.00017	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	9.43e-06	0.000169	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—malignant glioma	9.39e-06	0.000168	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTEN—malignant glioma	9.34e-06	0.000167	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—malignant glioma	9.26e-06	0.000166	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	9.11e-06	0.000163	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—malignant glioma	9.1e-06	0.000163	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NCOR1—malignant glioma	8.96e-06	0.000161	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CD—malignant glioma	8.95e-06	0.000161	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	8.91e-06	0.00016	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—malignant glioma	8.9e-06	0.00016	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	8.73e-06	0.000157	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—malignant glioma	8.64e-06	0.000155	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—malignant glioma	8.62e-06	0.000155	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—malignant glioma	8.57e-06	0.000154	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—malignant glioma	8.48e-06	0.000152	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	8.43e-06	0.000151	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KRAS—malignant glioma	8.41e-06	0.000151	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—malignant glioma	8.35e-06	0.00015	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—malignant glioma	8.03e-06	0.000144	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—malignant glioma	7.88e-06	0.000141	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—malignant glioma	7.85e-06	0.000141	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CB—malignant glioma	7.8e-06	0.00014	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—malignant glioma	7.76e-06	0.000139	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—malignant glioma	7.73e-06	0.000139	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	7.72e-06	0.000139	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—malignant glioma	7.71e-06	0.000138	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—malignant glioma	7.59e-06	0.000136	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—malignant glioma	7.47e-06	0.000134	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KRAS—malignant glioma	7.42e-06	0.000133	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CAV1—malignant glioma	7.31e-06	0.000131	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KRAS—malignant glioma	7.28e-06	0.000131	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—malignant glioma	7.28e-06	0.000131	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KRAS—malignant glioma	7.17e-06	0.000129	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	6.82e-06	0.000122	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTEN—malignant glioma	6.74e-06	0.000121	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	6.69e-06	0.00012	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.66e-06	0.000119	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—malignant glioma	6.59e-06	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	6.59e-06	0.000118	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—malignant glioma	6.47e-06	0.000116	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPARG—malignant glioma	6.42e-06	0.000115	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—malignant glioma	6.37e-06	0.000114	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—malignant glioma	6.31e-06	0.000113	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.85e-06	0.000105	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—malignant glioma	5.57e-06	9.99e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—malignant glioma	5.47e-06	9.81e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—malignant glioma	5.38e-06	9.65e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.1e-06	9.15e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—malignant glioma	5.05e-06	9.07e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.76e-06	8.53e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTEN—malignant glioma	4.41e-06	7.91e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—malignant glioma	3.88e-06	6.97e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.11e-06	5.58e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—malignant glioma	2.54e-06	4.56e-05	CbGpPWpGaD
